FI127024B - Multivalentteja yhdisteitä käytettäväksi aivovaurion hoidossa ja estämisessä - Google Patents
Multivalentteja yhdisteitä käytettäväksi aivovaurion hoidossa ja estämisessä Download PDFInfo
- Publication number
- FI127024B FI127024B FI20145861A FI20145861A FI127024B FI 127024 B FI127024 B FI 127024B FI 20145861 A FI20145861 A FI 20145861A FI 20145861 A FI20145861 A FI 20145861A FI 127024 B FI127024 B FI 127024B
- Authority
- FI
- Finland
- Prior art keywords
- tai
- suola
- joukosta
- yes
- yhdiste
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/44—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
- C07C235/58—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring with carbon atoms of carboxamide groups and singly-bound oxygen atoms, bound in ortho-position to carbon atoms of the same non-condensed six-membered aromatic ring
- C07C235/64—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring with carbon atoms of carboxamide groups and singly-bound oxygen atoms, bound in ortho-position to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
- C07C233/24—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
- C07C233/27—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring having the carbon atom of the carboxamide group bound to a carbon atom of an acyclic unsaturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/34—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
- C07C233/42—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
- C07C233/44—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring having the carbon atom of the carboxamide group bound to a carbon atom of an unsaturated carbon skeleton
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Emergency Medicine (AREA)
- Psychiatry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FI20145861A FI127024B (fi) | 2014-10-03 | 2014-10-03 | Multivalentteja yhdisteitä käytettäväksi aivovaurion hoidossa ja estämisessä |
US15/516,192 US9975846B2 (en) | 2014-10-03 | 2015-10-02 | Multivalent compounds for use in the treatment and prevention of brain damage |
EP15784732.8A EP3201173B1 (en) | 2014-10-03 | 2015-10-02 | Multivalent compounds for use in the treatment and prevention of brain damage |
ES15784732T ES2830386T3 (es) | 2014-10-03 | 2015-10-02 | Compuestos multivalentes para el uso en el tratamiento y la prevención del daño cerebral |
DK15784732.8T DK3201173T3 (da) | 2014-10-03 | 2015-10-02 | Multivalente forbindelser til anvendelse i behandlingen og forebyggelsen af hjerneskade |
PCT/FI2015/050659 WO2016051024A1 (en) | 2014-10-03 | 2015-10-02 | Multivalent compounds for use in the treatment and prevention of brain damage |
IL25140717A IL251407B (en) | 2014-10-03 | 2017-03-27 | A multivalent compound for the treatment and prevention of brain damage |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FI20145861A FI127024B (fi) | 2014-10-03 | 2014-10-03 | Multivalentteja yhdisteitä käytettäväksi aivovaurion hoidossa ja estämisessä |
Publications (2)
Publication Number | Publication Date |
---|---|
FI20145861A FI20145861A (fi) | 2016-04-04 |
FI127024B true FI127024B (fi) | 2017-09-29 |
Family
ID=54347566
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI20145861A FI127024B (fi) | 2014-10-03 | 2014-10-03 | Multivalentteja yhdisteitä käytettäväksi aivovaurion hoidossa ja estämisessä |
Country Status (7)
Country | Link |
---|---|
US (1) | US9975846B2 (fi) |
EP (1) | EP3201173B1 (fi) |
DK (1) | DK3201173T3 (fi) |
ES (1) | ES2830386T3 (fi) |
FI (1) | FI127024B (fi) |
IL (1) | IL251407B (fi) |
WO (1) | WO2016051024A1 (fi) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FI130262B (fi) | 2019-08-30 | 2023-05-17 | Medicortex Finland Oy | Koostumuksia ja koostumuksia käytettäväksi aivovaurion ja neurodegeneratiivisten sairauksien ennaltaehkäisemisessä tai hoitamisessa |
FR3123129B1 (fr) | 2021-05-22 | 2023-11-10 | Dreamtronic | Cadre a eclairage infrarouge d’ecran tactile, dote de diodes uvc |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH501037A (de) * | 1968-01-10 | 1970-12-31 | Ciba Geigy Ag | Verfahren zur Herstellung neuer wasserunlöslicher Azoverbindungen |
JP4342952B2 (ja) | 2002-04-03 | 2009-10-14 | プレバ、バイオテック、ソシエダッド、アノニマ | 神経変性疾患の防御のための天然フェノール系産物およびその誘導体 |
US8227643B2 (en) | 2002-05-31 | 2012-07-24 | Proteotech, Inc. | Sirtuin 1 and the treatment of neurodegenerative diseases |
US9422308B2 (en) | 2012-04-16 | 2016-08-23 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Derivatives of docosahexaenoylethanolamide and uses thereof |
-
2014
- 2014-10-03 FI FI20145861A patent/FI127024B/fi active IP Right Grant
-
2015
- 2015-10-02 EP EP15784732.8A patent/EP3201173B1/en active Active
- 2015-10-02 US US15/516,192 patent/US9975846B2/en active Active
- 2015-10-02 ES ES15784732T patent/ES2830386T3/es active Active
- 2015-10-02 WO PCT/FI2015/050659 patent/WO2016051024A1/en active Application Filing
- 2015-10-02 DK DK15784732.8T patent/DK3201173T3/da active
-
2017
- 2017-03-27 IL IL25140717A patent/IL251407B/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
IL251407A0 (en) | 2017-05-29 |
EP3201173B1 (en) | 2020-10-14 |
WO2016051024A1 (en) | 2016-04-07 |
EP3201173A1 (en) | 2017-08-09 |
IL251407B (en) | 2019-10-31 |
FI20145861A (fi) | 2016-04-04 |
DK3201173T3 (da) | 2020-11-16 |
US9975846B2 (en) | 2018-05-22 |
ES2830386T3 (es) | 2021-06-03 |
US20170298010A1 (en) | 2017-10-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2019204493B2 (en) | Pharmaceutical compositions comprising PPAR agonists and Nrf2 activators | |
CA2814371C (en) | Use of malononitrilamides in neuropathic pain | |
JP5738775B2 (ja) | ジスキネジア関連障害の治療 | |
AU2014204737A1 (en) | Solid solution compositions and use in severe pain | |
JP2004524337A (ja) | 異痛症および他の種々のタイプの慢性疼痛または幻肢痛を治療するための化合物のペプチドクラスの新規使用 | |
TW200808696A (en) | Alpha-aminoamide derivatives useful in the treatment of cognitive disorders | |
NL8203594A (nl) | Antiparkinsonmiddel. | |
US20160008336A1 (en) | Hdac inhibitors for the treatment of traumatic brain injury | |
FI127024B (fi) | Multivalentteja yhdisteitä käytettäväksi aivovaurion hoidossa ja estämisessä | |
ES2635353T3 (es) | Formas de dosificación y usos terapéuticos de la L-4-cloroquinurenina | |
KR20230121808A (ko) | 약제학적 활성 화합물로서 칸나비노이드 유도체 및이의 제조 방법 | |
US20120202860A2 (en) | Analgesic Compounds, Compositions and Uses Thereof | |
JP5749176B2 (ja) | トリプル再取込み阻害剤及びそれらの使用方法 | |
TW200418481A (en) | Method of treating movement disorders using barbituric acid derivatives | |
JP2016537375A (ja) | 神経変性疾患または認知障害を治療するためのインドリルおよびインドリニルヒドロキサメートの使用 | |
AU2018319549A1 (en) | Compositions and methods for ameliorating pain | |
KR101047387B1 (ko) | 뇌신경 보호를 위한 병용요법 | |
US20130225545A1 (en) | Porphyrin treatment of neurodegenerative diseases | |
JP2019509321A (ja) | 疼痛を処置するための組み合わせ | |
WO2012119045A2 (en) | Compositions and uses thereof to ameliorate pain | |
RU2752090C1 (ru) | Применение соединений для получения лекарственного средства для лечения геморрагического инсульта | |
CN113557018A (zh) | 急性带状疱疹疼痛的治疗剂 | |
KR101035522B1 (ko) | 뇌신경 보호를 위한 병용요법 | |
WO2014005720A1 (en) | Use of (r)-phenylpiracetam for the treatment of disease-associated fatigue | |
WO2013156232A1 (en) | Use of benzofuranylsulfonates in neuropathic pain |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Transfer of assignment of patent |
Owner name: HAREL |
|
FG | Patent granted |
Ref document number: 127024 Country of ref document: FI Kind code of ref document: B |